This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

23 Jul 2019

NTC news: Post-cataract surgery

Last June, in Milan, NTC held a very important Investigators’ Meeting of two pivotal registration studies for a novel drug indicated in post cataract surgery: over 50 centers were involved in such large clinical effort and attended the event.

NTC is fostering antibiotic culture in an environment largely impacted by antibiotic resistance, promoting innovation and creating new therapeutic solutions available on worldwide scale.

NTC‘s products are supported by significant evidence based medicine leveraging large randomized clinical trials.

Mentioned Companies
NTC S.r.l.
View company profile